Filter by Doctor (All Doctors) Dr. SanghaniDr. Gordon and Dr. GrumleyDr. O'Day Title Physician A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy NCT ID : 01872975 Dr. Sanghani Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer NCT ID : 03688204 Dr. Gordon and Dr. Grumley A Phase 1 Study of AGEN1181, an Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Subjects With Advanced Cancer NCT ID : NCT03860272 Protocol Number : C-800-01 Phase : 1 Dr. O'Day A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination With Ipilimumab or Nivolumab Monotherapy in Participants With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H) NCT ID : NCT03668119 Protocol Number : CA209-848 Phase : 2 Dr. O'Day
